0409-1401Level 3
Regadenoson (Regadenoson)
**Product type:** Human Prescription Drug
**Active ingredient:** REGADENOSON ANHYDROUS
**Strength:** .08 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Hospira, Inc.
**Marketing category:** ANDA (ANDA214349)
**Pharmacologic class:** Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC]
GET
/api/v1/systems/ndc_fda/nodes/0409-1401Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.